DR. YOGESH KUMAR GUPTA

DR. YOGESH KUMAR GUPTA

ASSOCIATE PROFESSOR


Medical Gastroenterology
MBBS, MD (Medicine), DM (Gastroenterology)
PMC-38740

About Doctor

Dr. Yogesh Kumar Gupta is a dedicated gastroenterologist with a special focus on endoscopy, colonoscopy, and ERCP procedures. He is known for his patient-cantered approach, combining advanced diagnostics with evidence-based care.

He is also an expert in managing liver diseases and pancreaticobiliary disorders. Dr. Gupta is recognized for delivering high-quality, advanced gastroenterological care. A distinguished doctor with more than 10 years of experience, he is known for offering the most comprehensive and state-of-the-art gastro services to each of his patients.

Specialization and Expertise

Medical Gastroenterology

OPD Timings

MON
08:00 AM to 01:30 PM
TUE
Not Available
WED
Not Available
THU
Not Available
FRI
08:00 AM to 01:30 PM
SAT
Not Available
SUN
Not Available
MON
08:00 AM to 04:00 PM
TUE
Not Available
WED
Not Available
THU
Not Available
FRI
08:00 AM to 04:00 PM
SAT
Not Available
SUN
Not Available

Certifications

  • Advanced endoscopic procedures and therapeutic interventions
  • Advanced management of gastrointestinal bleeding with endoscopic interventions
  • Inflammatory Bowel Disease (IBD)

Advanced medical therapies, biologics, and fecal microbiota transplantation (FMT).

  • Liver Failure & Portal Hypertension

Comprehensive management, including specialized interventions such as plasmapheresis.

  • Pancreaticobiliary Disorders

Endoscopic retrograde cholangiopancreatography (ERCP) and other advanced endoscopic techniques.

  • Functional & Motility Disorders

Integrating state-of-the-art diagnostics with tailored lifestyle and pharmacologic strategies.

  • Life Member Indian Society of Gastroenterology (ISG)
  • Life Member Colitis and Crohn's Foundation (India) [CCF(I)]

Publications

  • Singh A, Gupta YK, Dhaliwal AS, Kahlon BK, Bansal V, Mahajan R, Mehta V, Singh D, Kaur R, Bansal N, Midha V. Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD. Intestinal research. 2022 Oct 18;21(3):375-84

  •  Sood A, Singh A, Sudhakar R, Midha V, Mahajan R, Mehta V, Gupta YK, Kaur K. Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience. Intest Res. 2020 Feb 25;18(18):184-91
  • Gupta YK, Singh A, Narang V, Midha V, Mahajan R, Mehta V, Singh D, Bansal N, Durairaj MV, Dutta AK, Sood A. Clinical spectrum of elderly-onset inflammatory bowel disease in India. Intestinal research. 2023 Apr 1;21(2):216-25.

 

  • Mahajan R, Gupta Y, Singh A, Dhiman P, Midha V, Kakkar C, Narang V, Mehta V, Saggar K, Sood A. Clinical profile and outcomes of opioid abuse gastroenteropathy: an underdiagnosed disease entity. Intestinal research. 2020 Apr 1;18(2):238-44

 

  • Luthra M, Kakkar S, Mehta V, Gupta Y. Achieving High Sustained Viral Response in Difficult-to-Treat Hepatitis C-Infected Transfusion-Dependent Thalassemia Patients with Direct-Acting Antivirals. Journal of Clinical and Experimental Hepatology. 2023 Jan 1;13:S85-6

 

  • Sood A, Singh A, Mahajan R, Midha V, Mehta V, Gupta YK, Narang V, Kaur K. Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study). Journal of gastroenterology and hepatology. 2020 Mar;35(3):418-24.

 

 

  • Rare GI manifestation in amyloidosis: A case series. Corresponding Author – accepted to be published in journal named tropical Gastroenterology in Vol 40 no 4 (October – November 2019).

 

  • IDDF2019-ABS-0309 Gastro-intestinal ulcerations/strictures in opioid abusers published in Gut June 2019.

 

  • IDDF2019-ABS-0310 pattern of response to serial fecal microbiota transplantation via colonoscopic route in patients with ulcerative colitis published in Gut june 2019.

 

  • IDDF 2019-ABS-0313        Clinical factors affecting response to fecal microbiota transplantation in patients with active ulcerative colitis published in Gut june 2019.

  

  • Mahajan R, Midha V, Singh A, Mehta V, Gupta Y, Kaur K, Sudhakar R, Singh Pannu A, Singh D, Sood A. Incidental benefits after fecal microbiota transplant for ulcerative colitis. Intest Res. 2020 Jul;18(3):337-340. doi: 10.5217/ir.2019.00108. Epub 2020 Apr 22. PMID: 32306706; PMCID: PMC7385574.

 

Awards

  • Extensive international recognition for FMT research
  • Multiple publications in high-impact journals including New England Journal of Medicine
  • Leading expert in IBD management and advanced endoscopy
  • Invited speaker at national and international conferences
  • Mentor to numerous residents and fellows
logo

Enter at least 2 characters...

Enter at least 2 characters...

Enter at least 2 characters...

Enter at least 2 characters...

Enter at least 2 characters...